{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:07:37Z","timestamp":1788314857979,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR20046\/BIC\/101\/683\/2016"],"award-info":[{"award-number":["BT\/PR20046\/BIC\/101\/683\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10787-024-01486-z","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:01:36Z","timestamp":1715094096000},"page":"2109-2123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention"],"prefix":"10.1007","volume":"32","author":[{"given":"Padmini","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aradhika","family":"Vijeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharada","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa Gangadhar","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-9353","authenticated-orcid":false,"given":"Babitha Kampa","family":"Sundara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"1486_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.04.014","author":"S Ahmed","year":"2013","unstructured":"Ahmed S, Riegsecker S, Beamer M, Rahman A, Bellini JV, Bhansali P, Tillekeratne LV (2013) Largazole, a class I histone deacetylase inhibitor, enhances TNF-\u03b1-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts. Toxicol. https:\/\/doi.org\/10.1016\/j.taap.2013.04.014","journal-title":"Toxicol"},{"key":"1486_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205635","author":"C Angiolilli","year":"2014","unstructured":"Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Fernandez BM, van Es IE, Reedquist KA (2014) Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205635","journal-title":"Ann Rheum Dis"},{"key":"1486_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209064","author":"C Angiolilli","year":"2017","unstructured":"Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, Garc\u00eda S, Reedquist KA (2017) Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209064","journal-title":"Ann Rheum Dis"},{"key":"1486_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1638-4","author":"C Angiolilli","year":"2018","unstructured":"Angiolilli C, Kabala PA, Grabiec AM, Rossato M, Lai WS, Fossati G, Radstake TR (2018) Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-018-1638-4","journal-title":"Arthritis Res Ther"},{"key":"1486_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00188-x","author":"D Bae","year":"2021","unstructured":"Bae D, Choi Y, Lee J, Ha N, Suh D, Baek J, Son W (2021) M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib. Pharmacological Rep. https:\/\/doi.org\/10.1007\/s43440-020-00188-x","journal-title":"Pharmacological Rep"},{"key":"1486_CR6","doi-asserted-by":"publisher","DOI":"10.2741\/1817","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role i arthritis. Front Biosci. https:\/\/doi.org\/10.2741\/1817","journal-title":"Front Biosci"},{"key":"1486_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04857-2","author":"J Choi","year":"2023","unstructured":"Choi J, Gang S, Ramalingam M, Hwang J, Jeong H, Yoo J, Jang S (2023) BML-281 promotes neuronal differentiation by modulating Wnt\/Ca2+ and Wnt\/PCP signaling pathway. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-023-04857-2","journal-title":"Mol Cell Biochem"},{"key":"1486_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq108","author":"QY Choo","year":"2010","unstructured":"Choo QY, Ho PC, Tanaka Y, Lin HS (2010) Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-\u03baB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keq108","journal-title":"Rheumatology"},{"key":"1486_CR9","doi-asserted-by":"publisher","first-page":"14085","DOI":"10.3390\/molecules181114085","volume":"18","author":"QY Choo","year":"2013","unstructured":"Choo QY, Ho PC, Tanaka Y, Lin HS (2013) The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells. Molecules 18:14085","journal-title":"Molecules"},{"key":"1486_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s1525-0016(03)00235-1","author":"YL Chung","year":"2003","unstructured":"Chung YL, Lee MY, Wang AJ, Yao LF (2003) A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther. https:\/\/doi.org\/10.1016\/s1525-0016(03)00235-1","journal-title":"Mol Ther"},{"key":"1486_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.10.022","author":"KH Costenbader","year":"2012","unstructured":"Costenbader KH, Gay S, Alarc\u00f3n-Riquelme ME, Iaccarino L, Doria A (2012) Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. https:\/\/doi.org\/10.1016\/j.autrev.2011.10.022","journal-title":"Autoimmun Rev"},{"key":"1486_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105973","author":"SN Cui","year":"2019","unstructured":"Cui SN, Chen ZY, Yang XB, Chen L, Yang YY, Pan SW, Shang Y (2019) Trichostatin A modulates the macrophage phenotype by enhancing autophagy to reduce inflammation during polymicrobial sepsis. Int Immunopharmcol. https:\/\/doi.org\/10.1016\/j.intimp.2019.105973","journal-title":"Int Immunopharmcol"},{"key":"1486_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","volume":"18","author":"HA Elshabrawy","year":"2015","unstructured":"Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S (2015) The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis 18:433","journal-title":"Angiogenesis"},{"key":"1486_CR14","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00020","author":"A Furlan","year":"2011","unstructured":"Furlan A, Monzani V, Reznikov LL, Leoni F, Fossati G, Modena D, Dinarello CA (2011) Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat). Mol Med. https:\/\/doi.org\/10.2119\/molmed.2011.00020","journal-title":"Mol Med"},{"key":"1486_CR15","doi-asserted-by":"publisher","DOI":"10.2217\/17455057.4.2.195","author":"M Gerosa","year":"2008","unstructured":"Gerosa M, De Angelis V, Riboldi P, Meroni PL (2008) Rheumatoid arthritis: a female challenge. WHNP. https:\/\/doi.org\/10.2217\/17455057.4.2.195","journal-title":"WHNP"},{"key":"1486_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/art.33382","author":"J Gillespie","year":"2012","unstructured":"Gillespie J, Savic S, Wong C, Hempshall A, Inman M, Emery P, McDermott MF (2012) Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3\u2013selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.33382","journal-title":"Arthritis Rheum"},{"key":"1486_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102379","author":"L G\u00f6schl","year":"2020","unstructured":"G\u00f6schl L, Preglej T, Boucheron N, Saferding V, M\u00fcller L, Platzer A, Bonelli M (2020) Histone deacetylase 1 (HDAC1): a key player of T cell-mediated arthritis. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2019.102379","journal-title":"J Autoimmun"},{"key":"1486_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.17","author":"AM Grabiec","year":"2013","unstructured":"Grabiec AM, Reedquist KA (2013) The ascent of acetylation in the epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2013.17","journal-title":"Nat Rev Rheumatol"},{"key":"1486_CR19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901467","author":"AM Grabiec","year":"2010","unstructured":"Grabiec AM, Krausz S, De Jager W, Burakowski T, Groot D, Sanders ME, Reedquist KA (2010) Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.0901467","journal-title":"J Immunol"},{"key":"1486_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154211","author":"AM Grabiec","year":"2011","unstructured":"Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA (2011) Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard.2011.154211","journal-title":"Ann Rheum Dis"},{"key":"1486_CR21","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.34.1432","author":"MK Ha","year":"2011","unstructured":"Ha MK, Song YH, Jeong SJ, Lee HJ, Jung JH, Kim B, Kim SH (2011) Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes. Biol Pharm Bull. https:\/\/doi.org\/10.1248\/bpb.34.1432","journal-title":"Biol Pharm Bull"},{"key":"1486_CR22","doi-asserted-by":"publisher","DOI":"10.1042\/BST20130053","author":"S Hawtree","year":"2013","unstructured":"Hawtree S, Muthana M, Wilson AG (2013) The role of histone deacetylases in rheumatoid arthritis fibroblast-like synoviocytes. Biochem Soc Trans. https:\/\/doi.org\/10.1042\/BST20130053","journal-title":"Biochem Soc Trans"},{"key":"1486_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv258","author":"S Hawtree","year":"2015","unstructured":"Hawtree S, Muthana M, Wilkinson JM, Akil M, Wilson AG (2015) Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddv258","journal-title":"Hum Mol Genet"},{"key":"1486_CR24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081115","author":"M Horiuchi","year":"2009","unstructured":"Horiuchi M, Morinobu A, Chin T, Sakai Y, Kurosaka M, Kumagai S (2009) Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.081115","journal-title":"J Rheumatol"},{"key":"1486_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/jm201496g","author":"J Hou","year":"2012","unstructured":"Hou J, Li Z, Fang Q, Feng C, Zhang H, Guo W, Wang PG (2012) Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising lead. J Med Chem. https:\/\/doi.org\/10.1021\/jm201496g","journal-title":"J Med Chem"},{"key":"1486_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/art.22512","author":"LC Huber","year":"2007","unstructured":"Huber LC, Brock M, Hemmatazad H, Giger OT, Moritz F, Trenkmann M, J\u00fcngel A (2007) Histone deacetylase\/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.22512","journal-title":"Arthritis Rheum"},{"key":"1486_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.030","author":"T Ito","year":"2005","unstructured":"Ito T, Ouchida M, Morimoto Y, Yoshida A, Jitsumori Y, Ozaki T, Shimizu K (2005) Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Let. https:\/\/doi.org\/10.1016\/j.canlet.2004.10.030","journal-title":"Cancer Let"},{"key":"1486_CR28","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1186\/ar3071","volume":"12","author":"T Kawabata","year":"2010","unstructured":"Kawabata T, Nishida K, Takasugi K, Ogawa H, Sada K, Kadota Y, Makino H (2010) Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis. Arthritis Res Ther 12:R133","journal-title":"Arthritis Res Ther"},{"key":"1486_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01525","author":"DS Kim","year":"2018","unstructured":"Kim DS, Kwon JE, Lee SH, Kim EK, Ryu JG, Jung KA, Kwok SK (2018) Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01525","journal-title":"Front Immunol"},{"key":"1486_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.01.007","author":"K Klein","year":"2013","unstructured":"Klein K, Gay S (2013) Epigenetic modifications in rheumatoid arthritis, a review. Curr Opin Pharmacol. https:\/\/doi.org\/10.1016\/j.coph.2013.01.007","journal-title":"Curr Opin Pharmacol"},{"key":"1486_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2013.04.001","author":"S Kong","year":"2013","unstructured":"Kong S, Yeung P, Fang D (2013) The class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis. J Genet Genomics. https:\/\/doi.org\/10.1016\/j.jgg.2013.04.001","journal-title":"J Genet Genomics"},{"key":"1486_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0182-5","author":"PA Konstantinopoulos","year":"2006","unstructured":"Konstantinopoulos PA, Vandoros GP, Papavassiliou AG (2006) FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities. Cancer Chemother Pharmacol. https:\/\/doi.org\/10.1007\/s00280-005-0182-5","journal-title":"Cancer Chemother Pharmacol"},{"key":"1486_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06075-5","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(01)06075-5","journal-title":"Lancet"},{"key":"1486_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165771","author":"EC Lee","year":"2020","unstructured":"Lee EC, Kim YM, Lim HM, Ki GE, Seo YK (2020) The histone deacetylase inhibitor (MS-275) promotes differentiation of human dental pulp stem cells into odontoblast-like cells independent of the MAPK signaling system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165771","journal-title":"Int J Mol Sci"},{"key":"1486_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-013-9616-0","author":"M Li","year":"2013","unstructured":"Li M, Liu X, Sun X, Wang Z, Guo W, Hu F, Li Z (2013) Therapeutic effects of NK-HDAC-1, a novel histone deacetylase inhibitor, on collagen-induced arthritis through the induction of apoptosis of fibroblast-like synoviocytes. Inflammation. https:\/\/doi.org\/10.1007\/s10753-013-9616-0","journal-title":"Inflammation"},{"key":"1486_CR36","first-page":"1","volume":"2018","author":"Y Li","year":"2018","unstructured":"Li Y, Zhou M, Lv X, Song L, Zhang D, He Y, Wang D (2018) Reduced activity of HDAC3 and increased acetylation of histones H3 in peripheral blood mononuclear cells of patients with rheumatoid arthritis. J Immunol Res 2018:1","journal-title":"J Immunol Res"},{"key":"1486_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707165","author":"HS Lin","year":"2007","unstructured":"Lin HS, Hu CY, Chan HY, Liew YY, Huang HP, Lepescheux L, Cl\u00e9ment-Lacroix P (2007) Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. https:\/\/doi.org\/10.1038\/sj.bjp.0707165","journal-title":"Br J Pharmacol"},{"key":"1486_CR38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.229328","author":"RJ Lohman","year":"2016","unstructured":"Lohman RJ, Iyer A, Fairlie TJ, Cotterell A, Gupta P, Reid RC, Fairlie DP (2016) Differential anti-inflammatory activity of HDAC inhibitors in human macrophages and rat arthritis. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/jpet.115.229328","journal-title":"J Pharmacol Exp Ther"},{"key":"1486_CR39","doi-asserted-by":"publisher","first-page":"17489","DOI":"10.18632\/aging.203238","volume":"13","author":"X Lv","year":"2021","unstructured":"Lv X, Qiu J, Hao T, Zhang H, Jiang H, Tan Y (2021) HDAC inhibitor Trichostatin A suppresses adipogenesis in 3T3-L1 preadipocytes. Aging 13:17489","journal-title":"Aging"},{"key":"1486_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-007-7036-z","author":"H Manabe","year":"2008","unstructured":"Manabe H, Nasu Y, Komiyama T, Furumatsu T, Kitamura A, Miyazawa S, Nishida K (2008) Inhibition of histone deacetylase down-regulates the expression of hypoxia-induced vascular endothelial growth factor by rheumatoid synovial fibroblasts. Inflamm Res. https:\/\/doi.org\/10.1007\/s00011-007-7036-z","journal-title":"Inflamm Res"},{"key":"1486_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23802","author":"D Mao","year":"2023","unstructured":"Mao D, Jiang H, Zhang F, Yang H, Fang X, Zhang Q, Zhao G (2023) HDAC2 exacerbates rheumatoid arthritis progression via the IL-17-CCL7 signaling pathway. Environ Toxicol. https:\/\/doi.org\/10.1002\/tox.23802","journal-title":"Environ Toxicol"},{"key":"1486_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01645.x","author":"H Mizutani","year":"2010","unstructured":"Mizutani H, Hiraku Y, Tada-Oikawa S, Murata M, Ikemura K, Iwamoto T, Kawanishi S (2010) Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. Cancer Sci. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01645.x","journal-title":"Cancer Sci"},{"key":"1486_CR43","first-page":"1052","volume":"33","author":"A Morinobu","year":"2006","unstructured":"Morinobu A, Wang B, Liu J, Yoshiya S, Kurosaka M, Kumagai S (2006) Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts. J Rheumatol 33:1052\u20131060","journal-title":"J Rheumatol"},{"key":"1486_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390116","author":"D Mulherin","year":"1996","unstructured":"Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.1780390116","journal-title":"Arthritis Rheumatol"},{"key":"1486_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken003","author":"C Nakamura","year":"2008","unstructured":"Nakamura C, Matsushita I, Kosaka E, Kondo T, Kimura T (2008) Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/ken003","journal-title":"Rheumatology"},{"key":"1486_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/art.20709","author":"K Nishida","year":"2004","unstructured":"Nishida K, Komiyama T, Miyazawa SI, Shen ZN, Furumatsu T, Doi H, Asahara H (2004) Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21WAF1\/Cip1 expression. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.20709","journal-title":"Arthritis Rheumatol"},{"key":"1486_CR47","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra040226","author":"JR O'Dell","year":"2004","unstructured":"O\u2019Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmra040226","journal-title":"N Engl J Med"},{"key":"1486_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1357-2","author":"BR Oh","year":"2017","unstructured":"Oh BR, Suh DH, Bae D, H N, Choi YI, Yoo HJ, Song YW, (2017) Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-017-1357-2","journal-title":"Arthritis Res Ther"},{"key":"1486_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02258-0","author":"JK Park","year":"2020","unstructured":"Park JK, Jang YJ, Oh BR, Shin J, Bae D, Ha N, Song YW (2020) Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-020-02258-0","journal-title":"Arthritis Res Ther"},{"key":"1486_CR50","doi-asserted-by":"publisher","DOI":"10.1042\/bj20021321","author":"AJD Ruijter","year":"2003","unstructured":"Ruijter AJD, Gennip AHV, Caron HN, Kemp S, Kuilenburg ABV (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. https:\/\/doi.org\/10.1042\/bj20021321","journal-title":"Biochem J"},{"key":"1486_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.93","author":"AM Savino","year":"2017","unstructured":"Savino AM, Sarno J, Trentin L, Vieri M, Fazio G, Bardini M, Cazzaniga G (2017) The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL. Leukemia. https:\/\/doi.org\/10.1038\/leu.2017.93","journal-title":"Leukemia"},{"key":"1486_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","volume":"11","author":"S Shen","year":"2020","unstructured":"Shen S, Svoboda M, Zhang G, Cavasin MA, Motlova L, McKinsey TA, Kozikowski AP (2020) Structural and in vivo characterization of Tubastatin A, a widely used histone deacetylase 6 inhibitor. ACS Med Chem Lett 11:706","journal-title":"ACS Med Chem Lett"},{"key":"1486_CR53","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.99107s5661","author":"DA Smith","year":"1999","unstructured":"Smith DA, Germolec DR (1999) Introduction to immunology and autoimmunity. Environ. https:\/\/doi.org\/10.1289\/ehp.99107s5661","journal-title":"Environ"},{"key":"1486_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(03)00259-0","author":"SE Sweeney","year":"2004","unstructured":"Sweeney SE, Firestein GS (2004) Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Bio. https:\/\/doi.org\/10.1016\/s1357-2725(03)00259-0","journal-title":"Int J Biochem Cell Bio"},{"key":"1486_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem297","author":"T Thalhamer","year":"2008","unstructured":"Thalhamer T, McGrath MA, Harnett MM (2008) MAPKs and their relevance to arthritis and inflammation. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kem297","journal-title":"Rheumatology"},{"key":"1486_CR56","doi-asserted-by":"publisher","first-page":"e70939","DOI":"10.1371\/journal.pone.0070939","volume":"8","author":"E Toussirot","year":"2013","unstructured":"Toussirot E, Abbas W, Khan KA, Tissot M, Jeudy A, Baud L, Herbein G (2013) Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production. PLoS ONE 8:e70939","journal-title":"PLoS ONE"},{"key":"1486_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110644","author":"M Vijaykrishnaraj","year":"2023","unstructured":"Vijaykrishnaraj M, Patil P, Ghate SD, Bhandary AK, Haridas VM, Shetty P (2023) Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis. Int Immonopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.110644","journal-title":"Int Immonopharmacol"},{"key":"1486_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.03.016","author":"S Vishwakarma","year":"2013","unstructured":"Vishwakarma S, Iyer LR, Muley M, Singh PK, Shastry A, Saxena A, Narayanan S (2013) Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2013.03.016","journal-title":"Int Immunopharmacol"},{"key":"1486_CR59","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00030","author":"J Vojinovic","year":"2011","unstructured":"Vojinovic J, Damjanov N (2011) HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis. Mol Med. https:\/\/doi.org\/10.2119\/molmed.2011.00030","journal-title":"Mol Med"},{"key":"1486_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051082","author":"D Wu","year":"2022","unstructured":"Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Pang Y (2022) Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1051082","journal-title":"Front Immunol"},{"key":"1486_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.549656","author":"H Yuan","year":"2020","unstructured":"Yuan H, Jiao L, Yu N, Duan H, Yu Y, Bai Y (2020) Histone deacetylase 3-mediated inhibition of microRNA-19a-3p facilitates the development of rheumatoid arthritis-associated interstitial lung disease. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2020.549656","journal-title":"Front Physiol"},{"key":"1486_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21774","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang B (2016) Trichostatin A, an inhibitor of histone deacetylase, inhibits the viability and invasiveness of hypoxic rheumatoid arthritis fibroblast-like synoviocytes via PI3K\/Akt signaling. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.21774","journal-title":"J Biochem Mol Toxicol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01486-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01486-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:50:24Z","timestamp":1783500624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01486-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01486-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}